DRIO
vs
S&P 500
DRIO
S&P 500
Over the past 12 months, DRIO has underperformed S&P 500, delivering a return of -20% compared to the S&P 500's +14% growth.
Stocks Performance
DRIO vs S&P 500
Performance Gap
DRIO vs S&P 500
Performance By Year
DRIO vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
DarioHealth Corp
Glance View
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. The company is headquartered in New York City, New York and currently employs 200 full-time employees. The company went IPO on 2013-03-08. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. DarioHealth offers digital therapeutics solutions covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Its products include Dario Blood Glucose Monitoring Starter Kit and Dario Blood Pressure Monitoring System. Its Dario Blood Glucose Monitoring Starter Kit is pocket-sized smartphone blood glucose meter that measure sugar levels. Its Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all your readings in the Dario App. Its Dario mobile application, the Dario Blood sugar (glucose) meter enables to track and check blood sugar (glucose) in real-time.
